Because HM Complex targets fundamental cellular processesspecifically oxidative stress, mitochondrial function, and systemic toxic burdenit has the potential to support the management of a wide array of symptoms associated with complex chronic illnesses
Impaired vascular redox signaling in the vascular complications of obesity and diabetes mellitus
As we continue to add more medications that improve outcomes for patients with diabetic kidney disease, we will need to decide how we go about giving patients these medications, and we will need further trials to determine if there are benefits to being treated with as many kidney-protective medications as there are to offerSGLT2is, renin angiotensin system inhibitors, mineralocorticoid receptor antagonists, and now GLP-1 receptor agonists
Of the six mammalian FATP isoforms, FATP2 and FATP5 are found primarily in the liver [14]
Methymalonic-CoA enters the TCAC half way through the cycle as succinyl-CoA, thereby essentially short circuiting the TCAC (Figure 6b)
6 Their GLP-1-specific outcomes are still emerging
